DIABETES AND OBESITY BURDEN AND IMPROVEMENTS IN CARDIOMETABOLIC PARAMETERS IN PATIENTS WITH PSORIASIS OR PSORIATIC ARTHRITIS RECEIVING APREMILAST IN A REAL-WORLD SETTING
Published: 26 February 2024| Version 1 | DOI: 10.17632/zy52nd6c3w.1
Contributors:
Cristi Cavanaugh, Kate Orroth, Xi Qian, Pam Kumparatana, Yuri Klyachkin, Stephen Colgan, Myriam CordeyDescription
Mendeley Supplemental Materials for Cristi Cavanaugh et al. DIABETES AND OBESITY BURDEN AND IMPROVEMENTS IN CARDIOMETABOLIC PARAMETERS IN PATIENTS WITH PSORIASIS OR PSORIATIC ARTHRITIS RECEIVING APREMILAST IN A REAL-WORLD SETTING. JAAD International. 2024.
Files
Institutions
- Amgen Inc
- OM1 Inc
Categories
Diabetes, Obesity, Psoriatic Arthritis, Psoriasis, Body Mass Index
Funders
- Amgen (United States)United States